Altered patterns of gene expression in response to chronic atrial fibrillation

International Heart Journal

Volumn 46, Issue 3, 2005, Pages 383-395

  Kim, Nam Ho ^a,c   Ahn, Youngkeun ^b,e   Oh, Seok Kyu ^a,c   Cho, Jeong Kwan ^b   Park, Hyung Wook ^b   Kim, Yong Sook ^b   Hong, Moon Hwa ^b   Nam, Kwang Il ^e   Park, Woo Jin ^d   Jeong, Myung Ho ^b   Ahn, Byung Hee ^b   Choi, Jong Bum ^a,c   Kook, Hyun ^e   Park, Jong Chun ^b   Jeong, Jin Won ^a,c   Kang, Jung Chaee ^b  

^a Wonkwang University Hospital   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

^e Chonnam National University   (South Korea)

Author keywords

Apoptosis; Atrial fibrillation; Atrial tissue; Gene expression

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; COMPLEMENTARY DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P27; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DNA GEL BLOT ANALYSIS; DNA MICROARRAY; ELECTRON MICROSCOPY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINUS RHYTHM; WESTERN BLOTTING; AGAR GEL ELECTROPHORESIS; CASE CONTROL STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; UPREGULATION;

ADULT; AGED; APOPTOSIS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DOWN-REGULATION; ELECTROPHORESIS, AGAR GEL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ANGIOTENSIN, TYPE 2; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 26044470173     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.46.383     Document Type: Article

References (27)

1. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-95.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-68.
3. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94: 2968-74.
4. Ausma J, Wijffels M, Thone F, Wouters L, Allessie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997; 96: 3157-63.
5. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.
6. Li D, Fareh S. Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999; 100: 87-95.
7. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997; 96: 1686-95.
8. Nitta T, Imura H, Bessho R, Hosaka H, Yamauchi S, Tanaka S. Wavelength and conduction inhomogeneity in each atrium in patients with isolated mitral valve disease and atrial fibrillation. J Cardiovasc Electrophysiol 1999; 10: 521-8.
9. Aime-Sempe C, Folliguet T, Rucker-Martin C, et al. Myocardial cell death in fibrillating and dilated human right atria. J Am Coll Cardiol 1999; 34: 1577-86.
10. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation 2000; 101: 2678-81.
11. Goette A, Lendeckel U, Klein HU. Signal transduction systems and atrial fibrillation. Cardiovasc Res 2002; 54: 247-58. (Review)
12. Yang YH, Dudoit S, Luu P. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002; 30: e15.
13. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-21.
14. Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res 2002; 91: 559-64. (Review)
15. James TN. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994; 90: 556-73. (Review)
16. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E. Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways. Cardiovasc Res 2003; 60: 315-25.
17. Rogg H, de Gasparo M, Graedel E. et al. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J 1996; 17: 1112-20.
18. Asano K, Dutcher DL, Port JD, et al. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 1997; 95: 1193-200.
19. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998; 83: 1182-91. (Review)
20. Boldt A, Wetzel U, Weigl J, et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J Am Coll Cardiol 2003; 42: 1785-92.
21. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-82.
22. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-5. (Review)
23. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-63. (Review)
24. Maejima Y, Adachi S, Ito H, Nobori Y, Tamamori-Adachi M, Isobe M. Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovasc Res 2003; 59:308-20.
25. Reis ED, Roque M, Cordon-Cardo C, Drobnjak M, Fuster V, Badimon JJ. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vasc Surg 2000; 32: 1022-9.
26. Philipp-Staheli J, Payne SR, Kemp CJ. p27 (Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264: 148-68. (Review)
27. Burton PB, Yacoub MH, Barton PJ. Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J 1999; 20: 604-11.